We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cabazitaxel in Platinum Refractory Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01747239
Recruitment Status : Terminated (Too low inclusion rate. Only 4 patients included over 16 months)
First Posted : December 11, 2012
Last Update Posted : December 4, 2014
Sponsor:
Collaborator:
Sanofi
Information provided by (Responsible Party):
Vejle Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : July 2014
  Study Completion Date : July 2014